ABOUT US

P5 Health Ventures invests in early to mid-stage digital health+care technology companies that exponentially improve human life while generating societal benefits and financial returns. These companies are redefining how health is perceived and achieved as well as how and what care is delivered. The fund primarily invests in software platform driven companies that include devices and services that directly integrate the companies with their consumer while collecting valuable data.

Manifesto

There are a few points that we want to get across about what we are doing here at P5 that is quite different from our peers.

WE:

  1. Are a people driven social impact investor. Each investment we embrace will have or already has a significant impact on population / patient health
  2. Expect to be a major factor in transforming healthcare for everyone – patients and consumers, dramatically improving quality, accessibility and outcomes, while lowering cost 
  3. Invest in companies that dramatically improve healthcare NOW, the new platforms of today that can lead the way forward 
  4. Are patient but aggressive
  5. Only invest in platforms that have multiple ways to succeed and contribute to society 
  6. Are focused on leading, in some cases cutting edge, but not bleeding edge
  7. Leverage our podcast and media platforms to educate the industry and invite healthy dialog and change in healthcare 
  8. Will always stay true to the P5 mission of making better care available to all 
  9. Are friendly activist venture capitalists 
  10. Embrace diversity of thought and empathy for others as CORE VALUES

Areas of Interest

P5 Health Ventures invests in companies that are near or well into revenues. We are primarily if not solely interested in companies that make healthcare accessible to all, that have a major impact on wellness and healthcare by making it easier to use, improve its quality, lowering its cost and improving its accessibility. Specific areas includes:

  • Patient signal platforms that create, manage and make sense of those signals – into biomarkers
  • Disease Management (Chronic disease, behavioral health, autoimmune, etc.)
  • Consumer-Driven Healthcare
  • Population Health Management + Value-based Care + Preventive Care
  • Diagnostics (Class I, II patient-oriented)Telehealth + Remote Monitoring
  • Nutrition + Consumption
  • Other areas of our interest include technologies that will drive down the costs of care and make high quality healthcare accessible for all

Round

P5HV is primarily focused on Seed – Series B companies that are near revenue generation (<18 months) or currently have revenues and clear exit paths.

Typical Investment Size:

– Seed: Up to $1M + co-investment opportunities
– Series A/B: Up to $3.5M + co-investment opportunities